TEK and breast cancer: In a mouse model of HER2+ breast cancer, researchers found that overexpression of HER2 could induce the production of CCL2 by cancer cells and that myeloid cells attract CD206+/Tie2+ macrophages that promote the epithelial to mesenchymal transition in HER2+ breast cancer cells 27.